Literature DB >> 18055930

Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis.

Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, Robin M Murray, Paul M Grasby, Philip K McGuire.   

Abstract

The dopamine hypothesis has been the major pathophysiological theory of psychosis in recent decades. Molecular imaging studies have provided in vivo evidence of increased dopamine synaptic availability and increased presynaptic dopamine synthesis in the striata of people with psychotic illnesses. These studies support the predictions of the dopamine hypothesis, but it remains to be determined whether dopaminergic abnormalities pre-date or are secondary to the development of psychosis. We selectively review the molecular imaging studies of the striatal dopaminergic system in psychosis and link this to models of psychosis and the functional subdivisions of the striatum to make predictions for the dopaminergic system in the prodromal phase of psychosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055930      PMCID: PMC3796874          DOI: 10.1192/bjp.191.51.s13

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  73 in total

Review 1.  The dopamine hypothesis of schizophrenia: a review.

Authors:  H Y Meltzer; S M Stahl
Journal:  Schizophr Bull       Date:  1976       Impact factor: 9.306

2.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.

Authors:  C S Patlak; R G Blasberg
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

Review 3.  The neuropathology of schizophrenia.

Authors:  J E Kleinman; M F Casanova; G E Jaskiw
Journal:  Schizophr Bull       Date:  1988       Impact factor: 9.306

4.  The dopamine hypothesis: an overview of studies with schizophrenic patients.

Authors:  J L Haracz
Journal:  Schizophr Bull       Date:  1982       Impact factor: 9.306

5.  Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.

Authors:  J L Martinot; P Peron-Magnan; J D Huret; B Mazoyer; J C Baron; J P Boulenger; C Loc'h; B Maziere; V Caillard; H Loo
Journal:  Am J Psychiatry       Date:  1990-01       Impact factor: 18.112

6.  Provocative tests with psychostimulant drugs in schizophrenia.

Authors:  J A Lieberman; J M Kane; J Alvir
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 7.  Beyond the dopamine hypothesis. The neurochemical pathology of schizophrenia.

Authors:  G P Reynolds
Journal:  Br J Psychiatry       Date:  1989-09       Impact factor: 9.319

8.  Positron tomographic quantitation of neuroreceptors in human brain in vivo--with special reference to the D2 dopamine receptors in caudate nucleus.

Authors:  A Gjedde; D F Wong
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

9.  Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.

Authors:  D F Wong; H N Wagner; L E Tune; R F Dannals; G D Pearlson; J M Links; C A Tamminga; E P Broussolle; H T Ravert; A A Wilson; J K Toung; J Malat; J A Williams; L A O'Tuama; S H Snyder; M J Kuhar; A Gjedde
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

10.  Uptake of 77Br-spiperone in the striata of schizophrenic patients and controls.

Authors:  J C Crawley; T J Crow; E C Johnstone; S R Oldland; F Owen; D G Owens; T Smith; N Veall; G D Zanelli
Journal:  Nucl Med Commun       Date:  1986-08       Impact factor: 1.690

View more
  49 in total

1.  Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations.

Authors:  Oliver D Howes; Paul Shotbolt; Michael Bloomfield; Kirstin Daalman; Arsime Demjaha; Kelly M J Diederen; Kemal Ibrahim; Euitae Kim; Philip McGuire; René S Kahn; Iris E Sommer
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

2.  Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies.

Authors:  Paolo Fusar-Poli; Andreas Meyer-Lindenberg
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

3.  Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) density.

Authors:  Paolo Fusar-Poli; Andreas Meyer-Lindenberg
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

4.  New insights into the organization of the basal ganglia.

Authors:  James B Koprich; Tom H Johnston; Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

5.  Distinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognition.

Authors:  Stefan Borgwardt; Nikolaos Koutsouleris; Jacqueline Aston; Erich Studerus; Renata Smieskova; Anita Riecher-Rössler; Eva M Meisenzahl
Journal:  Schizophr Bull       Date:  2012-09-11       Impact factor: 9.306

Review 6.  Recent advances in parametric neuroreceptor mapping with dynamic PET: basic concepts and graphical analyses.

Authors:  Seongho Seo; Su Jin Kim; Dong Soo Lee; Jae Sung Lee
Journal:  Neurosci Bull       Date:  2014-09-28       Impact factor: 5.203

Review 7.  Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia.

Authors:  Shinichiro Nakajima; Hiroyoshi Takeuchi; Eric Plitman; Gagan Fervaha; Philip Gerretsen; Fernando Caravaggio; Jun Ku Chung; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero
Journal:  Schizophr Res       Date:  2015-02-13       Impact factor: 4.939

Review 8.  Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.

Authors:  Trevor Archer; Serafino Ricci; Danilo Garcia; Max Rapp Ricciardi
Journal:  Neurotox Res       Date:  2014-05-08       Impact factor: 3.911

9.  Dopaminergic contributions to hippocampal pathophysiology in schizophrenia: a computational study.

Authors:  Peter J Siekmeier; David P vanMaanen
Journal:  Neuropsychopharmacology       Date:  2014-01-28       Impact factor: 7.853

Review 10.  Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia.

Authors:  Urs Meyer; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2009-03-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.